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The international charter on prevention of fetal alcohol 
spectrum disorder
The ﬁ rst international conference on prevention of fetal 
alcohol spectrum disorders was held in Edmonton, AB, 
Canada, on Sept 23–25, 2013. The conference resulted 
in the production, endorsement, and adoption of the 
following international charter on the prevention 
of fetal alcohol spectrum disorder by more than 
700 people from 35 countries worldwide, including 
senior government oﬃ  cials, scholars and policymakers, 
clinicians and other front-line service providers, parents, 
families, and indigenous people. It is presented to all 
concerned in the international community as a call for 
urgent action to prevent fetal alcohol spectrum disorder.
Fetal alcohol spectrum disorder is a serious health 
and social problem, as well as an educational and legal 
issue, which aﬀ ects individuals, families, and societies 
worldwide. The disorder is caused by alcohol use during 
pregnancy—no known amount of alcohol is safe for a 
growing embryo and fetus, which can develop extensive 
brain damage and physical abnormalities from exposure 
to alcohol. Although early intervention and supportive 
care can improve outcomes for individuals with fetal 
alcohol spectrum disorder, the associated cognitive, 
behavioural, and physical impairments can have 
devastating implications for the individual, family, and 
other caregivers.1 Fetal alcohol spectrum disorder is a 
lifelong disorder.
The cause and consequences of fetal alcohol spectrum 
disorder have been known for 40 years, yet the disorder 
continues to aﬄ  ict millions of people worldwide—about 
one in every 100 livebirths.2 In countries where drinking 
among women of childbearing age is common, the 
prevalence of fetal alcohol spectrum disorder can be 
substantially higher. This disorder is of overwhelming 
concern in some populations.3
Fetal alcohol spectrum disorder is preventable. However, 
one major obstacle to prevention is lack of awareness 
of the disorder’s existence and of risks associated with 
women drinking alcohol during pregnancy. Opinion-
based advice and conﬂ icting messages from diﬀ erent 
studies about presumed safe amounts of maternal alcohol 
consumption cause confusion and contribute to a failure 
to perceive the risk of fetal alcohol spectrum disorder. 
Findings from basic research have shown clearly that 
even low to moderate consumption of alcohol can cross 
the placenta and interfere with the normal development 
of the embryo and fetus. Heavy or frequent alcohol 
use increases the risk of giving birth to a baby with fetal 
alcohol spectrum disorder.4
People with fetal alcohol spectrum disorder have 
additional challenges as a result of their disorder, such as 
breakdown in family relations, disruption of schooling, 
unemployment, homelessness, and alcohol and drug 
misuse.5 Adolescents and adults with fetal alcohol 
spectrum disorder are also at high risk of encounters 
with the criminal justice system, either as oﬀ enders or 
victims.6 Many individuals go to jail and become repeat 
oﬀ enders and are often victimised themselves.7 The 
ﬁ nancial burden of fetal alcohol spectrum disorder on 
families, communities, and governments is substantial. 
To address their complex needs, individuals with fetal 
alcohol spectrum disorder often require additional 
support in health, social, educational, legal, and 
correctional services. The associated ﬁ nancial costs 
are unsustainable for many countries. The cost of 
people ignoring the problem and not taking action for 
prevention is going to further increase the strain on 
scarce societal resources.8
Although maternal alcohol consumption during 
pregnancy is the direct cause of fetal alcohol spectrum 
disorder, many underlying causes exist for drinking 
during pregnancy.9 Reasons include women having 
little information about the risks of drinking while 
pregnant, drinking before pregnancy is recognised, 
dependence on alcohol, untreated mental health 
disorders, and social pressures to drink. The complex 
biological and social determinants of health, including 
genetics, poverty, malnutrition, and poor social support 
networks and personal autonomy, also aﬀ ect drinking 
behaviour and the severity of its results to the fetus. 
The risk of alcohol-exposed pregnancy increases with 
adverse life events, gender-based violence, trauma, 
stress, and social isolation. Whatever the reasons for 
women drinking during pregnancy, eﬀ ective prevention 
strategies need to be identiﬁ ed and addressed within 
the social, economic, and cultural context of every 
community.
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The perception that fetal alcohol spectrum disorder 
is aﬀ ected only by a woman’s choices is a major 
barrier to eﬀ ective prevention eﬀ orts. Men also have 
a responsibility. Women’s drinking behaviour, and 
therefore fetal alcohol spectrum disorder, occurs within, 
and is aﬀ ected by, a broad familial, cultural, and social 
context. Partners who show little to no support during 
pregnancy and who might also misuse alcohol, become 
violent, and demand that their pregnant partner drink 
with them, share responsibility for the outcome. Social 
norms that promote drinking for pregnant women 
are also responsible for increasing risk of fetal alcohol 
spectrum disorder. Providers of health care and social 
services are responsible when they do not inform 
about the risks of drinking during pregnancy, do not 
provide meaningful support to help pregnant women 
to abstain from alcohol, or do not assist families to 
secure adequate nutrition during crucial times. Alcoholic 
beverage marketing that targets women of childbearing 
age without cautioning about the use of the products 
during pregnancy is also responsible. Society is 
responsible for failing to help pregnant women to cope 
with fear, anxiety, violence, malnutrition, and poor 
health through means other than alcohol use. The risks 
associated with the underlying determinants of health 
are a societal challenge.
This charter calls on governments to take action to 
raise awareness of fetal alcohol spectrum disorder and 
the risks of alcohol use during pregnancy. Governments 
must promote a consistent, evidence-based message 
about prevention by supporting the development and 
circulation of public health information that is clear 
and consistent: to abstain from alcohol use during 
pregnancy is the only certain way to prevent fetal 
alcohol spectrum disorder. This information must be 
widely available in every country, responsive to local 
contexts, and designed to allow access to supportive 
services for pregnant women. In addition, policies 
related to the social determinants of health should 
explicitly address fetal alcohol spectrum disorder; its 
implications for the individual, family, and society; 
and how it can be prevented. Access to reliable and 
aﬀ ordable contraceptives is an important concern. 
Prevention of fetal alcohol spectrum disorder should 
be given a larger role in the development of alcohol 
policies. The responsibility for prevention of fetal alcohol 
spectrum disorder should not be placed on women 
alone. Prevention is a shared duty. Actions should focus 
on information about the risks of alcohol use during 
pregnancy, access to reliable contraceptives, and help to 
deal with addiction and abstinence from alcohol during 
pregnancy. This support includes provision of timely, 
compassionate, and competent prenatal care.
Although public knowledge of fetal alcohol spectrum 
disorder is high in some countries, it is very low 
worldwide. Assessment of awareness at the population 
level is an important foundation for making decisions 
about targeted or general strategies for prevention. 
Most countries do not have population-level prevalence 
data for alcohol use during pregnancy and for fetal 
alcohol spectrum disorder; in other countries, data are 
only available for some geographic areas and for speciﬁ c 
populations. Research on the incidence and prevalence 
of fetal alcohol spectrum disorder should be coordinated 
within and between countries to guide prevention 
eﬀ orts and set benchmarks to measure the success of 
speciﬁ c approaches to prevention. Diagnosis of the full 
range of disorders needs expertise that is not present in 
most countries. International collaboration in diagnosis 
of fetal alcohol spectrum disorder should therefore be 
encouraged as a major step to build diagnostic capacity 
and link this knowledge to primary and secondary 
prevention.
Much research on fetal alcohol spectrum disorder 
is needed. For example, genetic and epigenetic 
mechanisms that might either facilitate or protect 
against development are not fully understood. Basic 
research might lead to the development of methods 
to more accurately identify high-risk groups and 
to new opportunities for targeted prevention. For 
applied research and evaluation, reliable ﬁ ndings are 
needed from controlled prevention trials of how to 
reduce the prevalence and incidence of fetal alcohol 
spectrum disorder. Programmes for prevention must 
include resources for assessment of their eﬀ ectiveness. 
Additional basic and applied research has the potential 
to increase knowledge about prevalence and of 
prevention strategies that are truly eﬀ ective and cost 
eﬀ ective.
Several practical and evidence-based methods can 
be introduced for use in many countries, regions, 
or communities to help to prevent fetal alcohol 
spectrum disorder. For example, general information 
about the disorder can be provided to both girls and 
Comment
www.thelancet.com/lancetgh   Vol 2   March 2014 e137
boys in appropriate school settings by making use 
of evidence-based informative materials. Screening 
for problematic alcohol use in girls and women of 
childbearing age is also crucial because results might 
signal a risk of alcohol use in pregnancy. Screening can be 
done in primary care using already available, validated, 
and easy-to-use instruments. Evidence-based guidelines 
for treatment of alcohol abuse in pregnant women are 
available in published work10 and on many websites. 
Informative materials about fetal alcohol spectrum 
disorder in regionally-speciﬁ c languages, and that are 
relevant to local cultures and systems, are needed. Such 
materials should be made widely available, particularly in 
schools, clinics, and centres for maternal and child health 
care. National and international funding agencies and 
organisations should support such activities, which could 
be organised in cross-country collaborations.
When more than a million babies are born every 
year with permanent brain injury from a known and 
preventable cause, response should be immediate, 
determined, sustainable, and eﬀ ective. Broad-based 
policy initiatives and actions at diﬀ erent levels of every 
society are urgently needed to encourage abstinence 
from alcohol during pregnancy and to prevent fetal 
alcohol spectrum disorder.
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